{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:07:40Z","timestamp":1771002460212,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","labmed.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.cll.2016.01.004","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T13:15:46Z","timestamp":1456924546000},"page":"401-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Screening for Open Neural Tube Defects"],"prefix":"10.1016","volume":"36","author":[{"given":"David A.","family":"Krantz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Terrence W.","family":"Hallahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan B.","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7835","key":"10.1016\/j.cll.2016.01.004_bib1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S0140-6736(73)92592-0","article-title":"Prenatal diagnosis of anencephaly through maternal serum-alphafetoprotein measurement","volume":"2","author":"Brock","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2016.01.004_bib2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/jama.1977.03270470023006","article-title":"Progress in screening for neural tube defects","volume":"237","author":"Macri","year":"1977","journal-title":"JAMA"},{"key":"10.1016\/j.cll.2016.01.004_bib3","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/0002-9378(84)90530-1","article-title":"An association between low maternal serum alpha-fetoprotein and fetal chromosomal abnormalities","volume":"148","author":"Merkatz","year":"1984","journal-title":"Am J Obstet Gynecol"},{"issue":"3","key":"10.1016\/j.cll.2016.01.004_bib4","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000001051","article-title":"Committee Opinion No. 640: cell-free DNA screening for fetal aneuploidy","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0002-9378(96)70429-5","article-title":"Prenatal maternal dried blood screening with alpha-fetoprotein and free beta-human chorionic gonadotropin for open neural tube defect and Down syndrome","volume":"174","author":"Macri","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib6","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/j.1471-0528.1981.tb01759.x","article-title":"The effect of maternal weight on maternal serum alpha-fetoprotein levels","volume":"88","author":"Wald","year":"1981","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/j.cll.2016.01.004_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1056\/NEJM198803173181104","article-title":"Lack of relation of increased malformation rates in infants of diabetic mothers to glycemic control during organogenesis","volume":"318","author":"Mills","year":"1988","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.01.004_bib8","first-page":"960","article-title":"Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy","volume":"82","author":"Henriques","year":"1993","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/pd.72","article-title":"Biochemical screening for chromosomal disorders and neural tube defects (NTD): is adjustment of maternal alpha-fetoprotein (AFP) still appropriate in insulin-dependent diabetes mellitus (IDDM)?","volume":"21","author":"Sancken","year":"2001","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cll.2016.01.004_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00125817-200505000-00010","article-title":"Technical standards and guidelines: prenatal screening for open neural tube defects","volume":"7","author":"Bradley","year":"2005","journal-title":"Genet Med"},{"issue":"2","key":"10.1016\/j.cll.2016.01.004_bib11","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/jech.36.2.87","article-title":"Fourth report of the UK collaborative study on alpha-fetoprotein in relation to neural tube defects. Estimating an individual\u2019s risk of having a fetus with open spina bifida and the value of repeat alpha-fetoprotein testing","volume":"36","year":"1982","journal-title":"J\u00a0Epidemiol Community Health"},{"key":"10.1016\/j.cll.2016.01.004_bib12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0002-9378(89)90501-2","article-title":"Predictive values, relative risks, and overall benefits of high and low maternal serum alpha-fetoprotein screening in singleton pregnancies: new epidemiologic data","volume":"161","author":"Milunsky","year":"1989","journal-title":"Am J Obstet Gynecol"},{"issue":"2","key":"10.1016\/j.cll.2016.01.004_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/pd.1970100202","article-title":"Maternal serum alpha-fetoprotein screening for open neural tube defects in twin pregnancies","volume":"10","author":"Cuckle","year":"1990","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cll.2016.01.004_bib14","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/0002-9378(83)91198-5","article-title":"Estimates of birth prevalence rates of spina bifida in the United States from computer-generated maps","volume":"145","author":"Greenberg","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib15","first-page":"67","article-title":"Neural tube defects: issues in prenatal diagnosis and counseling","volume":"1","author":"Main","year":"1986","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(82)90908-4","article-title":"Maternal valproic acid and congenital neural tube defects","volume":"320","author":"Robert","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/j.cll.2016.01.004_bib17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJM199103073241006","article-title":"Spina bifida in infants of women treated with carbamazepine during pregnancy","volume":"324","author":"Rosa","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cll.2016.01.004_bib18","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/jms.7.2.74","article-title":"Assay precision of serum alpha fetoprotein in antenatal screening for neural tube defects and Down\u2019s syndrome","volume":"7","author":"Wald","year":"2000","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.cll.2016.01.004_bib19","first-page":"513","article-title":"Use of folic acid for prevention of spina bifida and other neural tube defects\u20141983\u20131991","volume":"40","author":"Centers for Disease Control (CDC)","year":"1991","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.cll.2016.01.004_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1469-0705.1997.09010014.x","article-title":"Ultrasound screening for anencephaly at 10\u201314\u00a0weeks of gestation","volume":"9","author":"Johnson","year":"1997","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1471-2393-8-33","article-title":"Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis","volume":"8","author":"Morris","year":"2008","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/j.cll.2016.01.004_bib22","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/pd.3932","article-title":"Second-trimester maternal serum markers and placenta accreta","volume":"32","author":"Dreux","year":"2012","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.cll.2016.01.004_bib23","first-page":"277","article-title":"Second-trimester maternal serum alpha-fetoprotein and risk of adverse pregnancy outcome","volume":"97","author":"Krause","year":"2001","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib24","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/01.AOG.0000172419.37410.eb","article-title":"Quad screen as a predictor of adverse pregnancy outcome","volume":"106","author":"Dugoff","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib25","first-page":"562","article-title":"Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high risk population","volume":"94","author":"Lennon","year":"1999","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.cll.2016.01.004_bib26","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jms.7.4.169","article-title":"Evaluation of prenatal diagnosis of neural tube defects by fetal ultrasonographic examination in different centres across Europe","volume":"7","author":"Boyd","year":"2000","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.cll.2016.01.004_bib27","series-title":"Maternal-fetal medicine principals and practice","first-page":"235","article-title":"Prenatal diagnosis of congenital disorders","author":"Jenkins","year":"2004"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121630004X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S027227121630004X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T17:55:24Z","timestamp":1536947724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S027227121630004X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S027227121630004X"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.004","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Open Neural Tube Defects","name":"articletitle","label":"Article Title"},{"value":"Clinics in Laboratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cll.2016.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}